Daewoong Pharmaceutical Invites Argentine Medical Staff to Host Nabota Master Class in Latin America
Nov 11, 2025
|
Last year, Daewoong Pharmaceutical's Nabota exceeded Argentina's high regulatory hurdles and was the first and only domestic botulinum toxin drug to obtain product approval. It is currently being sold under the brand name CLODEW through its partner Oxapharma.
In addition to educational marketing for local medical staff, Daewoong Pharmaceutical and Oxapama are also actively promoting marketing activities aimed at the MZ generation consumer group who pursue 'natural and sophisticated beauty' centered on digital platforms and SNS.
At this event, a number of systematic education programs centered on the independent procedures 'NaboLift' and 'NaboGlow' were conducted.
NaboLift, developed by Daewoong Pharmaceutical, injects Nabota into the skin and muscle layers to induce complex beauty effects such as facial contour lifting and wrinkle improvement. Naboglow is a treatment that can be expected to improve skin quality.
Participants learned the clinical effects and actual procedures of Nabota through lectures by Park Ji-ho and Kim Chang-hyun of Cheongdam Oaro Dermatology Department, and had time to observe the vivid procedure site through live demonstrations. In addition, Daewoong Pharmaceutical's manufacturing quality and global-level technology were confirmed through a tour of Korean medical institutions and the Hyangnam Nabota plant.
Yoon Jun-su, head of Nabota's business division at Daewoong Pharmaceutical, said, `Argentina is one of the top three healthcare markets in Latin America, and the number of plastic surgery people per 1,000 people is the second largest in the world, so public interest in beauty and plastic surgery is high.' We will try to target diversity in the local market by strengthening medical training and marketing to consumers of the MZ generation, and through this, we will make efforts to establish Nabota as a premium brand loved throughout Latin America beyond Argentina.'
This article was translated by Naver AI translator.
